Key result
Long non-coding RNAs are emerging as master regulators of cardiac metabolism, offering potential therapeutic targets to modulate metabolic pathways and improve cardiac regeneration following injury.
Why the study?
Understanding of the metabolic determinants and pathways that can promote cardiac regeneration in the injured heart remains limited, prompting discussion on whether exploiting lncRNAs and metabolic signaling could improve cardiac regenerative strategies.
Modulating the interplay between long non-coding RNAs and metabolic signaling pathways may provide novel therapeutic strategies for cardiac regeneration after injury.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for lncRNA-targeted cardiac therapies; requires prospective trials before clinical consideration.
Heart disease is the leading cause of mortality in developed countries. The associated pathology is typically characterized by the loss of cardiomyocytes that leads, eventually, to heart failure. Although conventional treatments exist, novel regenerative procedures are warranted for improving cardiac regeneration and patients well fare. Whereas following injury the capacity for regeneration of adult mammalian heart is limited, the neonatal heart is capable of substantial regeneration but this capacity is lost at postnatal stages. Interestingly, this is accompanied by a shift in the metabolic pathways and energetic fuels preferentially used by cardiomyocytes from embryonic glucose-driven anaerobic glycolysis to adult oxidation of substrates in the mitochondria. Apart from energetic sources, metabolites are emerging as key regulators of gene expression and epigenetic programs which could impact cardiac regeneration. Long non-coding RNAs (lncRNAs) are known master regulators of cellular and organismal carbohydrate and lipid metabolism and play multifaceted functions in the cardiovascular system. Still, our understanding of the metabolic determinants and pathways that can promote cardiac regeneration in the injured hearth remains limited. Here, we will discuss the emerging concepts that provide evidence for a molecular interplay between lncRNAs and metabolic signaling in cardiovascular function and whether exploiting this axis could provide ground for improved regenerative strategies in the heart.
No takes yet. Share an insight, caveat, or question.
Correia et al. (2021) conducted a review in Heart disease and cardiac regeneration. Long non-coding RNAs (lncRNAs) and metabolic modulation was evaluated. Long non-coding RNAs are emerging as master regulators of cardiac metabolism, offering potential therapeutic targets to modulate metabolic pathways and improve cardiac regeneration following injury.
Synapse has enriched 10 related papers. Consider them for comparative context: